ProCE Banner Activity

Updates in High-Risk HR+ and/or gBRCAm+ Early-Stage Breast Cancer

Slideset Download
Downloadable slides on individualizing perioperative treatment for patients with high-risk HR-positive and/or germline BRCA–mutated early-stage breast cancer.

Released: June 03, 2022

Expiration: June 02, 2023

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Lilly

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Jennifer K. Litton, MD

Associate Professor of Medicine
Department of Breast Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas